REVENUES: € 110.9 million in Q2’14, in line with Q2’13 revenues at CER, with molecular business contribution equal to € 0.9 million. 

DiaSorin (FTSE Mid Cap:DIA) is proud to announce the launch of its novel 1,25 Dihydroxyvitamin D assay for the quantitative determination of 1,25 Dihydroxyvitamin D levels in human serum and plasma, available on the LIAISON XL analyzer for the market outside the US only.

 

Dialog

New communication area.
To download technical Assays information